# FDA Inspection 1122259 - Reproductive Medicine Institute - February 05, 2020

Source: https://www.keypedia.com/records/fda_inspections/reproductive-medicine-institute/9e6319d3-19da-41a5-abd8-af2f35766e59
Source feed: FDA_Inspections

> FDA Inspection 1122259 for Reproductive Medicine Institute on February 05, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1122259
- Company Name: Reproductive Medicine Institute
- Inspection Date: 2020-02-05
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1122259 - 2020-02-05](https://www.keypedia.com/records/fda_inspections/reproductive-medicine-institute/23214536-3b55-4476-a93e-58101a469f75)
- [FDA Inspection 1045293 - 2018-02-08](https://www.keypedia.com/records/fda_inspections/reproductive-medicine-institute/abd1b9f7-932d-4458-a3f5-24c2dc56f9d3)
- [FDA Inspection 960979 - 2016-01-13](https://www.keypedia.com/records/fda_inspections/reproductive-medicine-institute/326e27a8-1aa1-4cb2-aa9e-41ea5e8e2ae2)
- [FDA Inspection 813531 - 2013-01-18](https://www.keypedia.com/records/fda_inspections/reproductive-medicine-institute/e4cff895-8efb-443e-8118-7bcc26d0e2ea)

Company: https://www.keypedia.com/companies/reproductive-medicine-institute/3f437b59-fb18-438b-bb0a-9e2c5d275c06

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d